Non-classical estrogen signaling inhibits melanoma and improves response to PD-1 blockade
Christopher A. Natale(University of Pennsylvania), Todd W. Ridky(University of Pennsylvania)
Cited by 2
Related Papers
Endogenous DOPA inhibits melanoma through suppression of CHRM1 signaling
|Science Advances|2022|24
LNS8801 inhibits Acute Myeloid Leukemia by Inducing the Production of Reactive Oxygen Species and Activating the Endoplasmic Reticulum Stress Pathway
|Cancer Research Communications|2023|9
ZIP9 is a Druggable Determinant of Sex Differences in Melanoma
|bioRxiv (Cold Spring Harbor Laboratory)|2020|4